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model, GDM increased the risk of adverse outcomes that included
neonatal intensive care unit (NICU), macrosomia, HDP, LGA, pre-
mature delivery and cesarean delivery in the model of 2010. The
value of adjusted RR (95%CI) were: 2.38(1.36-4.18), 2.13 (1.48-3.07),
2.01(1.17-3.46), 1.67 (1.36-2.04), 1.48(1.02-2.15), 1.44 (1.26-1.63),
respectively. The incidence of adverse maternal outcomes of GDM
subjects in 2010 (78.50%) was less than that (94.68%) in 2001
(X2¼13.22, P<0.01).
CONCLUSIONS GDM had a close relationship with adverse perinatal
outcomes in both 2001 and 2010. The rank of above outcomes had
changed in different stages, with the most serious outcome being
macrosomia in 2001 and NICU in 2010. Although the maternal out-
comes have improved over the past 10 years, further efforts are
needed to reduce adverse neonatal outcomes.GW26-e4793
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OBJECTIVES The systematic review was to assess the comparative
effects of GLP-1 RAs on glycemic control, hypoglycemia and treatment
discontinuation for treating type 2 diabetes.
METHODS We searched MEDLINE, EMBASE, the Cochrane library,
and www.clinicaltrials.gov from inception to June 1, 2014. Ran-
domized controlled trials comparing a GLP-1 RA with placebo, active
anti-diabetic drugs, or other kinds of GLP-1 RAs for type 2 diabetes
were included. We only considered the doses of GLP-1 RAs used in
routine clinical practice. Eligible trials should have available data on
the outcomes of HbA1c <7%, hypoglycemia or treatment discon-
tinuation, with the follow-up of at least 8 weeks. The revised
JADAD scale was used to assess risk of bias of the included studies.
Network meta-analysis using multivariate model with multi-arm
trials adjusted was conducted. We applied loop-speciﬁc approach to
test the assumption of consistency. Ranking of treatment effects
was based on probability shown by the surface under the cumula-
tive ranking curve.
RESULTS From a total of 1139 retrieved records, 78 eligible trials
with 34,685 patients were included. 13 different treatments
compared in the network included daily exenatide, weekly exena-
tide, liraglutide, albiglutide, taspoglutide, lixisenatide, dulaglutide,
sitagliptin, insulin, thiazolidinedione, sulphanylureas, metformin,
and Placebo. The mean and standard deviation of JADAD scores was
5.60 and 1.36, indicating overall low risk of bias of the trials. No
signiﬁcant differences were found on the outcome of HbA1c<7%
between any of GLP-1 RAs and any of traditional anti-diabetes
treatments. However, daily exenatide, liraglutide, taspoglutide and
lixisenatide induced signiﬁcantly less hypoglycemia (odds ratio
(95%CI): 0.63 (0.43, 0.93), 0.42 (0.25, 0.71), 0.43 (0.23, 0.81), 0.43
(0.22, 0.81), respectively) but signiﬁcantly higher treatment
discontinuation (odds ratio (95%CI): 2.50 (1.33, 5.00), 2.42 (1.29,
4.78), 5.51 (2.71, 12.08), 2.28 (1.02, 5.32), respectively) than insulin.
Compared with sulphanylureas there was signiﬁcant reduction in
hypoglycemia but higher discontinuation in GLP-1 RAs. Any of the
GLP-1 RAs had similar odds of hypoglycemia or discontinuation to
metformin. Weekly exenatide ranked top on the outcome of
HbA1c <7%, sulphanylureas and taspoglutide may have the most
serious problem on hypoglycemia and treatment discontinuation
respectively. 13.7% (10/73), 1.5% (2/128) and 13.4% (7/52) loops
were inconsistent respectively for the outcome of HbA1c <7%,
hypoglycemia and treatment discontinuation, suggesting overall
consistency.
CONCLUSIONS GLP-1 RAs may have similar efﬁcacy of lowering
HbA1c to traditional anti-diabetes treatments and probably induce
less hypoglycemia and higher treatment discontinuation. Insufﬁcient
number of trials in some pairwise comparisons may produce statistical
inconsistency and uncertainty of the results, which require further
robust evidence from well-designed trials.GW26-e1839
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OBJECTIVES Exercise is considered a protective factor in the pre-
vention of type 2 diabetes (T2D), though its role as a sole treatment for
pre-diabetes remains unknown. The present meta-analysis compares
the effect of exercise-only to exercise-diet interventions on plasma
glucose levels among a pre-diabetic population.
METHODS A literature search using PUBMED, EMBASE and
COCHRANE databases yielded 12 studies for analysis. Cochrane Col-
laborations tool and the Jadad scale were used to assess the quality of
the included articles. A random effects model was used to calculate
the pooled effect. Weighted mean difference (WMD) was calculated to
indicate the change of fast glucose level. Meta-regression was un-
dertaken to explore the impact of risk of bias for the included studies
and the forest plot was conducted to explore the relationship between
interventions.
RESULTS A total of 4,021 subjects were included in the analysis,
2,045 of them in the intervention group and 1,976 in the control
group. Compared to the exercise-only interventions, the exercise-
diet interventions showed a signiﬁcant effect on decreasing fasting
plasma glucose (Z¼12.06, P<0.05). The subgroup effect of exercise-
only interventions did not produce a statistically signiﬁcant result
(Z¼1.91, P>0.05), however, it still revealed a clinically signiﬁcant
decrease in fasting plasma glucose(WMD¼-0.19, 95%CI:-0.18,0.00).
According to four different intervention periods, the shortest period
intervention (less than 1year) did not display a signiﬁcant effect for
glucose control (Z¼1.35, P>0.05). and its WMD (95% CI) was
-0.12 mmol/L (-0.20,0.05). There was a signiﬁcant effect (Z¼7.19,
P<0.05) in 1-year subgroup. The longer the intervention period was,
the higher the subtotal effect was. The pooled effect in 3 years
subgroup was the highest with WMD(95% CI)¼-0.24 mmol/L
(-0.22,0.15). When participants were divided into two groups ac-
cording to age, individuals within 40-55 years was included into
younger subgroup and all others were assigned to elderly subgroup.
No signiﬁcant subgroup pooled effects were found in younger
subgroup (Z¼1.65, P>0.05). However, in elderly subgroup, there was
a signiﬁcant effect(Z¼10.31, P<0.05). In the two groups, the subtotal
effects were -0.27(-0.60,0.05) and-0.19(-0.22,-0.15), respectively. As
for different regions, signiﬁcant heterogeneity existed among
studies conducted in America and China, but not in Europe
(I2¼47.00%). The subtotal effect was varied indifferent regions. The
studies conducted among the European population displayed a
higher subtotal effect and its WMD was -0.22, its 95% CI was (-0.27,
-0.17) with Z¼8.01 and P<0.05.
CONCLUSIONS These results indicated both exercise-only and exer-
cise-diet intervention have displayed effect on decreasing the fasting
plasma glucose, with a better results in later group. The pooled effect
was more signiﬁcant in longer intervention period, elderly age group
and European group.
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OBJECTIVES To determine the incidences of gestational diabetes
mellitus (GDM) in Shanghai in two time points (2001 and 2010)
respectively, and to further evaluate whether or not these risk factors
of GDM have changed over time.
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11241 women who delivered in Shanghai First Maternity and Infant
Hospital and Shanghai Tenth People’s Hospital. Multivariate logistic
regression analysis was conducted to explore potential risk factors
of GDM. Moreover, longitudinal comparison of ten years period
were made.
RESULTS According to National Diabetes Data Group (NDDG) Stan-
dard, the incidences of GDM were 2.69% and 5.59% in 2001 and 2010,
respectively. The older were the subjects group, the higher the inci-
dence of GDM would be both in 2001 and 2010 (P < 0.01), and the
incidences of GDM in two subgroups (25-29 yrs, 30-34 yrs group) were
higher in 2010 than those in 2001. In addition, the incidence of GDM
increased signiﬁcantly with elevated body mass index (BMI) in 2010
(P < 0.01). As shown in multivariate logistic regression models,
BMI and hemoglobin were independent risk factors for GDM in 2001,
Odds ratio (OR) values and its 95% conﬁdence interval (CI) were 2.54
(1.12-5.75) and 1.04 (1.01-1.06), respectively. However, independent
risk factors for GDM in 2010 included BMI  24 kg/m2, obstetric ab-
normality, history of diabetes and systolic blood pressure, OR value
and 95%CI were 2.06 (1.63-2.61), 1.44 (1.04-2.00), 3.02 (1.94-4.72), 1.01
(1.00-1.02). Noteworthy, maternal age was also an independent risk
factor for GDM in 2010, the older were the subjects group, the higher
OR would be. OR (95%CI) of three subgroups (25-29 yrs, 30-34 yrs and
over 35 yrs group) were 2.81 (1.30-6.06), 4.70 (2.18-10.15), 7.99 (3.59-
17.76), respectively. Height was a protective factor for GDM, its OR
(95%CI) was 0.98 (0.97-0.99).
CONCLUSIONS The increasing incidence of GDM in combined with
changes of risk factors indicates a signiﬁcant public burden on health
services. More effective management and timely intervention
regarding these high-risk pregnancies will also need to be addressed
in the future.GW26-e2968
Selenium prevents from atherosclerosis formation by maintaining
antioxidant activation through the Akt/ GSK3b/ Nrf2 axis in diabetes
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OBJECTIVES The essential trace element, selenium (Se), has multiple
biological activities. The present study aimed to evaluate the effect of
antioxidant capacity mobilized by selenium-regulated Nrf2 on
atherosclerosis formation in diabetes mellitus and possible
mechanisms.
METHODS 20 male Sprague- Dawley rats were randomly assigned into
2 groups: STZ-induced diabetes with Se supplementation group
(DMþSeS, 1 mg selenium/kg diet was given for 5 weeks every day) and
STZ-induced diabetes with Se-deﬁcient group (DMþSeD, 0.05mg
selenium/kg diet was given for 5 weeks every day). Atherosclerotic
plaques were stained with Oil-red-O and counterstained with hema-
toxylin. Both oxidative stress and antioxidant capacity were
measured. Expression of phosphorylation of Akt/GSK3b and Nrf2 and
Fyn expression were examined by Western blot.
RESULTS Compared with DMþSeD, Se supplementation in diabetic
rats signiﬁcantly increased serum Se levels (12620ug/L in SeS vs.
4015 ug/L in SeD group, P<0.05) and inhibited atherosclerotic pla-
ques formation along with increased antioxidant selenoenzymes
glutathione peroxidase (GPx) activity(31%, P<0.05), the GSH concen-
tration (18%, P<0.05) and HO-1 expression(23%, P<0.05) in artery
tissue. Contrarily, decreased ROS generation and lipid peroxidation
(LP) levels were observed. Se supplementation also showed a signif-
icant enhance in nuclear factor-erythroid 2-related factor 2 (Nrf2)
expression and transcription action along with signiﬁcant increases in
Akt and GSK-3b phosphorylation, and decrease in nuclear accumula-
tion of Fyn (a Nrf2 negative regulator). In vitro study with endothelial
cells showed that high glucose-induced oxidative stress could be
completely prevented by simultaneous Se supplementation.
Furthermore, increased phosphorylation of Akt and GSK3b and Nrf2
transcription action by Se addition were also blocked by the Akt in-
hibitor MK2206 and Akt negative regulators PTEN, which was
accompanied by increase in nuclear accumulation of Fyn.
CONCLUSIONS It is suggested that Se is required for maintaining
antioxidant activation through the Akt/ GSK3b/ Fyn -Nrf2/ axis indiabetic condition. Se supplementation may be useful for preventing
from atherosclerosis development in diabetes.GW26-e1008
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OBJECTIVES The aim of this study was to compare the outcomes of
invasive versus conservative strategy in diabetes mellitus (DM) pa-
tients with acute coronary syndrome (ACS).
METHODS 9 randomized, controlled trials (RCT) involving 1,789 pa-
tients were included. We evaluated the risk ratios (RR) and 95%
conﬁdence intervals (Cls) of myocardial infarction (MI) following
invasive versus conservative strategy for DM patients with ACS as
primary endpoints. The rates of death and rehospitalization with ACS
were secondary endpoints.
RESULTS In a comparison of conservative strategy, the rates of MI
(RR: 0.71; 95% CI: 0.55 to 0.92, p < 0.01) and rehospitalization with
ACS (RR: 0.75; 95% CI: 0.61 to 0.92, p < 0.01) of invasive strategy for
DM patients with ACS were signiﬁcantly lower. There was no signiﬁ-
cant difference in death (RR: 1.01; 95% CI: 0.70 to 1.45, p > 0.05) be-
tween invasive and conservative strategy groups.
CONCLUSIONS In DM patients with ACS, invasive strategy comparing
with conservative strategy reduced the risk of MI and rehospitaliza-
tion with ACS.GW26-e2329
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OBJECTIVES AEML is the aqueous extract from Mulberry leaf which
can inhibit the active of a- Glycosidase. This study is to investigate the
effect of AEML on the Glycaemic Index (GI) of common carbohydrates
in Chinese healthy subjects.
METHODS A seven-period, self-crossover, open-label clinical trial
was performed to 15 healthy male and female volunteers. In each
period, all the subjects received a mixture of sugar þ test substance
dissolved in water as a meal. Reference meal is Glucose 50 g, while
test meals are Glucose 50 g þ AEML 750 mg, Maltose 50 g þ AEML
750 mg, Sucrose 50 g þ AEML 750 mg and Maltodextrin 50 g þ
AEML 750 mg. Each subject randomly received the reference meal
three times and the test meal once in a cycle. There was a 2-day
washout period between each administration. The blood samples
were taken from ﬁnger-prick at –15 min, 0 min and intervals of 15,
30, 45, 60, 90 and 120 min after consuming the test/reference
meals. These incremental area under the curve (IAUC) of blood
sugar–time curve were inspected about reference meal and test
meals.
RESULTS The GI of common carbohydrates treated by AEML is great
difference compared with no AEML groups. The IAUC values for
Glucose, Glucose þ AEML, Maltose þ AEML, Sucrose þ AEML and
Maltodextrin þ AEML were 181.9553.56, 170.8442.28,
107.1354.68, 90.4032.30, and 126.7336.00 (mmol/L$min), respec-
tively. Furthermore, the GI value of Glucose, Maltose, Sucrose and
Maltodextrin were 94, 59, 50 and 70, less than the corresponding re-
ported value 100, 105, 65 and 110, respectively.
CONCLUSIONS AEML can reduce the GI level of Glucose, Maltose,
Sucrose and Maltodextrin in healthy male and female volunteers. It
has potential to serve as a good food additives for diabetic or predi-
abetic patients.
